BPG is committed to discovery and dissemination of knowledge
Randomized Controlled Trial
©Author(s) (or their employer(s)) 2026.
World J Clin Pediatr. Mar 9, 2026; 15(1): 111304
Published online Mar 9, 2026. doi: 10.5409/wjcp.v15.i1.111304
Table 1 Baseline characteristics of study participants, n (%)/median (25th-75th percentiles)/mean ± SD
Characteristics
BES (n = 30)
NS (n = 30)
P value
Age (years)10.77 ± 1.3610.63 ± 1.50.72
Female23 (76.7)21 (70)0.56
Anthropometric parameters
Weight (kg)19.2 ± 6.519.5 ± 6.40.84
Height (cm)131.2 ± 24.1130.9 ± 24.30.77
BMI (kg/m2)19.6 ± 3.419.4 ± 3.50.92
Socio-economic status (poor)6 (20)5 (16.7)0.63
Family history of diabetes3 (10)2 (6.7)0.44
Known case of diabetes10 (33.3)11 (36.7)0.59
Age (year) at onset of diabetes5 ± 25 ± 20.99
Previous history of DKA16 (53.3)17 (56.7)0.73
Precipitating event present15 (50)17 (56.7)0.42
Infection present9 (30)7 (23.3)0.39
Poor compliance17 (56.7)18 (60)0.65
Severity of DKA at presentation
Mild2 (3.3)2 (6.7)
Moderate7 (6.9)8 (3.3)0.39
Severe21 (70)20 (66.7)
Shock at presentation2 (6.7)1 (3.3)0.17
GCS at admission13 ± 213 ± 20.97
Blood glucose (mg/dL)452 (364-548)448 (354-542)0.48
Hb1Ac (%)9.8 (8.8-12)9.6 (8.6-11.5)0.76
Laboratory parameters
Blood pH7.01 (6.9-7.18)7.02 (6.9-7.2)0.59
PCO220 (15-23)19 (16-22)0.71
HCO3 (mmol/L)7.2 (5.6-10.1)7 (5.5-9.5)0.81
Lactate (mmol/L)2 (1-3)2 (1-3)0.93
Anion gap (mmol/L)16 (14-20)17 (14-19)0.77
Serum osmolality (mmol/kg)296 (291-310)298 (293-310)0.56
Sodium (corrected) (meq/L)136 (132-139)138 (134-141)0.84
Potassium (meq/L)3.9 (3.4-4.2)3.7 (3.4-4.1)0.51
Phosphate (mg/dL)3.4 (3.1-4)3.8 (3.2-4)0.48
Chloride (meq/L)108 (104-112)106 (101-110)0.59
Renal function test
Urea (mg/dL)35 (28-61)32 (25-54)0.23
Creatinine (mg/dL)0.7 (0.4-1.2)0.7 (0.5-1.3)0.65


Write to the Help Desk